Next Generation TB Drug Combinations from the Pan-TB Consortium: Combination Efficacy and Contributions of Individual Agents, Evaluated in a BALB/c Mouse TB Model
Sylvie Sordello, Alain Le Coupanec, Zoï Vahlas, Chiara Roversi, ROBERTO VISENTIN, Xavier Boulenc, Denise Federico, Simone Zannoni, Simone Modolo, Augusto Celon, Roberto Petterlini, Cécile Pascal, Fanny Deglave, Alessia Tagliavini, Marco Pergher, , Anna M. Upton
The paper evaluates next-generation TB drug combinations in a mouse model, showing some regimens cure 90% of mice in under 2 months with faster sterilizing efficacy than existing treatments.
bioRxiv · Jun 23, 2026 · PreprintPharmacology & Toxicology